Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.55 |
| ▸ | TFPI | P10646 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 1/20 | 0.53 |
| ▸ | GCGR | P47871 | 1/20 | 0.53 |
| ▸ | GIPR | P48546 | 1/20 | 0.53 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182935 | 0.90 | TFPI (0.62) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL29811053 | 0.89 | IL23R (0.59) | IL23ROPRM1OPRD1OPRK1TFPI | |
| SCHEMBL30668120 | 0.88 | OPRM1 (0.60) | OPRM1OPRD1OPRK1TFPIGLP1R | |
| SCHEMBL30567786 | 0.88 | TFPI (0.58) | TFPIGLP1RPTH1R | |
| SCHEMBL29609357 | 0.88 | TFPI (0.64) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL30083769 | 0.88 | TFPI (0.63) | IL23ROPRM1OPRD1OPRK1TFPI | |
| SCHEMBL30726528 | 0.87 | BACE1 (0.56) | TFPIGLP1RGCGRGIPR | |
| SCHEMBL30903291 | 0.87 | TFPI (0.63) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL29365490 | 0.87 | TFPI (0.62) | OPRM1OPRD1OPRK1TFPIGLP1R | |
| SCHEMBL31000935 | 0.87 | TFPI (0.65) | OPRM1OPRD1OPRK1TFPIGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |